A team led by University Distinguished Professor of Biology Kim Lewis received a five-year, $9 million grant from the National Institute of Health’s National Institute of Allergy and Infectious Diseases to launch a novel platform for developing antibiotics that kill pathogens without encountering resistance.
ICYMI: Reports of the arrival in the U.S. of a new superbug that is resistant to an antibiotic of last resort have set off alarm bells among public health officials. Northeastern professor Kim Lewis explains the new superbug, how worried we should be, and how it might be stopped.
Hospital-related staph infections are rampant, with hundreds of thousands being reported in the U.S. each year. Northeastern researcher Kim Lewis and his colleagues are at the forefront of developing new drugs to stop the trend.
Northeastern researcher Kim Lewis and his team have launched an all-out effort to find a cure for Lyme disease, which afflicts nearly 300,000 new people in the U.S. each year. Their efforts aim to bring relief to all patients, including those who suffer from a debilitating chronic version of the disease.
Northeastern University Distinguished Professor Kim Lewis has received a $1.5 million grant from the Steven & Alexandra Cohen Foundation to develop better treatments for Lyme disease.
When Slava Epstein first arrived in America, he had little more than his family, a smuggled cat, and an “enormous amount of data” from his research in Russia. In 2015, he was part of one of the world’s biggest scientific stories.
Each year for the past seven years, Foreign Policy selected the leading Global Thinkers whose contributions and work have changed lives and are shaping the world.
Phillip Strandwitz wants to raise $50,000 to help research whether bacteria in our guts play a role in depression and anxiety.
A new discovery by University Distinguished Professor Kim Lewis and his colleagues could advance customized treatments for people with relapsing bacterial infections.
A research team led by University Distinguished Professor Kim Lewis presents in a new paper that it has identified drug-tolerant persister cells in the bacterium that causes Lyme disease. The researchers also present a promising approach to potentially eradicating this and other infections.